Lok Sabha: Moms to Get More Leaves, Labourers To Work Longer Hours
The Union Cabinet gave ex-post facto approval to the amendments made to the Maternity Benefits Act, that aims to raise maternity leave for women from 12 weeks to 26 weeks.
The Cabinet also gave ex-post facto nod to for amendments in the Factories Act, which has already been introduced in the ongoing Monsoon Session of Parliament.
The Maternity Benefit Act, 1961, protects the employment of women during the time of her maternity and entitles her of a full paid absence from work — to take care for her child.It is applicable to all establishments employing 10 or more persons and the amendments will help around 1.8 million women workforce in the organised sector.
These amendments include increasing maternity leave from 12 weeks to 26 weeks for two surviving children and 12 weeks for more than two children, 12 weeks maternity leave to ‘commissioning or adoptive mothers' and a mandatory provision of a creche in respect of establishment having 50 or more employees, the statement said.
In the case of the Factories (Amendment) Bill, 2016, the approved amendments will give boost to manufacturing sector and facilitate ease of doing business with an aim to enhance employment opportunities, it added.
These amendments relate to increase in overtime hours from the existing 50 hours per quarter to 100 hours (Section 64) and existing 75 hours per quarter to 125 hours (Section 65).
Earlier in the day, Labour Minister Bandaru Dattatreya introduced the Factories (Amendment) Bill, 2016 in the Lok Sabha, that seeks to enhance the limit of overtime hours. The Bill that was opposed by several opposition parties, was passed by the Lower House after Congress, Left, TMC, JDU and IUML parties staged a walkout.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets